Antiplatelet Management for Coronary Heart Disease: Advances and Challenges

Keyphrases

• Coronary Artery Disease 100%
• Antiplatelet 100%
• Stable Coronary Artery Disease 66%
• Treatment Options 33%
• Leading Causes of Death 33%
• New Drugs 33%
• Thrombotic 33%
• Thrombosis 33%
• Long-term Safety 33%
• Recent Advances 33%
• Treatment Duration 33%
• Cardiovascular Mortality 33%
• Acute Coronary Syndrome 33%
• Percutaneous Coronary Intervention 33%
• Balloon Angioplasty 33%
• Thrombotic Complications 33%
• Interventionalist 33%
• Antiplatelet Agents 33%
• Coronary Disease 33%
• Adjunct Therapy 33%
• Thromboprophylaxis 33%
• Clopidogrel 33%
• Drug-eluting Stent 33%
• Optimal Duration 33%
• Sudden Cardiac Death 33%
• Antiplatelet Therapy 33%
• Antiplatelet Drugs 33%
• Dual Antiplatelet Therapy 33%
• Coronary Plaque Progression 33%
• Cardiac Catheterization Laboratory 33%
• Plaque Disruption 33%
• P2Y12 Antagonists 33%
• Plaque Rupture 33%

Medicine and Dentistry

• Ischemic Heart Disease 100%
• Antiplatelet 100%
• Antiplatelet Drug 40%
• Clinician 20%
• Thrombosis 20%
• Adjuvant Therapy 20%
• Heart Muscle Ischemia 20%
• Cardiac Catheterization 20%
• Percutaneous Coronary Intervention 20%
• Treatment Duration 20%
• Percutaneous Transluminal Angioplasty 20%
• Stenting 20%
• Cardiovascular Mortality 20%
• Thromboprophylaxis 20%
• Sudden Cardiac Death 20%
• Drug-Eluting Stent 20%
• Clopidogrel 20%
• Acute Coronary Syndrome 20%
• Treatment Option 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Ischemic Heart Disease 100%
• Antiplatelet 100%
• Antithrombocytic Agent 40%
• Heart Muscle Ischemia 20%
• Thrombosis 20%
• Cardiovascular Mortality 20%
• Acute Coronary Syndrome 20%
• Clopidogrel 20%
• Sudden Cardiac Death 20%